Dermatofibrosarcoma protuberans - PubMed
Review
. 1992 Mar-Apr;42(2):116-25.
doi: 10.3322/canjclin.42.2.116.
Affiliations
- PMID: 1540852
- DOI: 10.3322/canjclin.42.2.116
Free article
Review
Dermatofibrosarcoma protuberans
W B Laskin. CA Cancer J Clin. 1992 Mar-Apr.
Free article
Abstract
Dermatofibrosarcoma protuberans is an intermediate-grade sarcoma that arises in the dermis of the trunk, proximal extremities, and less commonly, in the head and neck area of adults. Dermatofibrosarcoma protuberans has a deceptively innocuous early clinical appearance and generally exhibits an indolent course for years before entering a rapid growth phase. Its locally invasive behavior results in early recurrence if prompt, wide excision is not performed. Dermatofibrosarcoma protuberans rarely metastasizes through the bloodstream or, less often, to locoregional lymph nodes after multiple local recurrences. Fibrosarcomatous areas within the tumor result in a more aggressive course. Although wide excision is the mainstay of therapy, recent trials using the Mohs' surgical approach suggest that this technique may have a role in the future treatment of this tumor.
Similar articles
-
Gupta B, Verma N, Khurana N, Kumar Jain S. Gupta B, et al. BMJ Case Rep. 2016 Jul 7;2016:bcr2016215427. doi: 10.1136/bcr-2016-215427. BMJ Case Rep. 2016. PMID: 27389726 Free PMC article.
-
Dermatofibrosarcoma protuberans.
Mikhail GR, Lynn BH. Mikhail GR, et al. J Dermatol Surg Oncol. 1978 Jan;4(1):81-4. doi: 10.1111/j.1524-4725.1978.tb00384.x. J Dermatol Surg Oncol. 1978. PMID: 201685
-
Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change.
Minter RM, Reith JD, Hochwald SN. Minter RM, et al. J Surg Oncol. 2003 Mar;82(3):201-8. doi: 10.1002/jso.10211. J Surg Oncol. 2003. PMID: 12619065
-
Dermatofibrosarcoma protuberans: clinicopathological aspects of an unusual cutaneous tumor.
Korkolis DP, Liapakis IE, Vassilopoulos PP. Korkolis DP, et al. Anticancer Res. 2007 May-Jun;27(3B):1631-4. Anticancer Res. 2007. PMID: 17595787 Review.
-
Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.
Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O. Llombart B, et al. Semin Diagn Pathol. 2013 Feb;30(1):13-28. doi: 10.1053/j.semdp.2012.01.002. Semin Diagn Pathol. 2013. PMID: 23327727 Review.
Cited by
-
Ouédraogo Nde NA, Ouédraogo NA, Bambara HA, Tiemtoré-Kambou BM, Traoré F, Zongo N, Ouédraogo MS, Tapsoba GP, Thouraya Chtioui A, Lamien/Sanou A. Ouédraogo Nde NA, et al. J Med Case Rep. 2017 Apr 8;11(1):96. doi: 10.1186/s13256-017-1257-8. J Med Case Rep. 2017. PMID: 28388964 Free PMC article.
-
Advances in the systemic treatment of cutaneous sarcomas.
Luke JJ, Keohan ML. Luke JJ, et al. Semin Oncol. 2012 Apr;39(2):173-83. doi: 10.1053/j.seminoncol.2012.01.004. Semin Oncol. 2012. PMID: 22484189 Free PMC article. Review.
-
Myxoid Dermatofibrosarcoma Protuberans of the Scrotum: Rare Tumor in an Uncommon Location.
Isse HM, Sereke SG, Erem G. Isse HM, et al. Int Med Case Rep J. 2022 Aug 29;15:457-462. doi: 10.2147/IMCRJ.S363320. eCollection 2022. Int Med Case Rep J. 2022. PMID: 36061636 Free PMC article.
-
Targeted therapy for dermatofibrosarcoma protuberans.
Abrams TA, Schuetze SM. Abrams TA, et al. Curr Oncol Rep. 2006 Jul;8(4):291-6. doi: 10.1007/s11912-006-0035-3. Curr Oncol Rep. 2006. PMID: 17254529 Review.
-
Advances in molecular characterization and targeted therapy in dermatofibrosarcoma protuberans.
Rutkowski P, Wozniak A, Switaj T. Rutkowski P, et al. Sarcoma. 2011;2011:959132. doi: 10.1155/2011/959132. Epub 2011 Mar 30. Sarcoma. 2011. PMID: 21559214 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical